stars 1 stars 2 stars 3

TheraSource is a growing biotech company located in the Greater New York area. Our mission is to develop novel anti-inflammatory therapeutics for the treatment of human diseases. TheraSource is currently focused on the development of newly-discovered molecules to treat patients with ischemic acute kidney injury (AKI) and acute radiation injury. TheraSource's R&D unit resides at The Feinstein Institute for Medical Research, which is equipped with a state-of-the-art preclinical testing facility. Our research team currently consists of 9 scientists with MD or PhD degrees in multidisciplinary areas, including protein chemistry, cell biology, immunology, pathophysiology, and clinical medicine. The company possesses 14 utility patents covering 5 molecules to treat selected inflammatory human diseases.

TheraSource, LLLC Questions

The TheraSource, LLLC annual revenue was $5 million in 2026.

Magic Summers is the CEO of TheraSource, LLLC.

2 people are employed at TheraSource, LLLC.

TheraSource, LLLC is based in Roslyn, New York.

The NAICS codes for TheraSource, LLLC are [5619, 561, 561990, 56, 56199].

The SIC codes for TheraSource, LLLC are [73, 738].

Top TheraSource, LLLC Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users